This is a competing renewal application for continuing support for a Center of Excellence in Hematology focused on Molecular Developmental Hematopoiesis. Recent progress in the molecular dissection of blood cell development has revealed extraordinary conservation of mechanisms among vertebrate species, such that parallel study of different organisms is both complementary and synergistic for discovery.
The aim of the work of this Center is the elucidation of mechanisms by which hematopoietic stem cells arise, enter the progenitor pool, and then commit to lineage differentiation. In order to achieve these goals, a program of gene discovery and functional analysis is undertaken in two genetic systems the mouse and zebrafish. Manipulation of genes in the mouse through homologous recombination offers a mean to test gene function in vivo within the intact animal throughout development. Zebrafish, a relatively recent model vertebrate organism affords the opportunity to screen for mutant phenotypes and then identify the affected genes either by positional cloning or candidate gene analysis. This Center is comprised of three COREs, whose functions complement each other. A mouse embryonic stem 9ES) cell and gene targeting core will facilitate the generation of targeted mice for members of the Center, a set of hematology and non-hematology investigators in the Harvard Medical Area and throughout Boston. A zebrafish core will maintain stocks of hematological mutants, educate and collaborate with members of the Center, and facilitate gene identification. A new core dedicated to functional genomics will provide infrastructure support for high throughput cDNA analysis, sequencing, and in situ hybridization. Its activities will complement the ES cell and zebrafish cores and lead to rapid cross-species analysis of gene function. In addition to these CORES, the Center will provide a small pilot project program and support local seminars and meetings on developmental development should provide new insights into possible approaches to stem cell expansion and management of leukemias in the future. The Center will also serve to promote interactions and collaborations in hematological research within the Boston area and in this manner move research in the field ahead and recruit new investigators to molecular hematology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
3P30DK049216-07S1
Application #
6450496
Study Section
Special Emphasis Panel (ZDK1 (M1))
Program Officer
Badman, David G
Project Start
1994-09-30
Project End
2004-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
7
Fiscal Year
2001
Total Cost
$33,500
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Vo, Linda T; Kinney, Melissa A; Liu, Xin et al. (2018) Regulation of embryonic haematopoietic multipotency by EZH1. Nature 553:506-510
Mandelbaum, Joseph; Shestopalov, Ilya A; Henderson, Rachel E et al. (2018) Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. J Exp Med 215:2673-2685
Yamauchi, Takuji; Masuda, Takeshi; Canver, Matthew C et al. (2018) Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS. Cancer Cell 33:386-400.e5
Blaser, Bradley W; Zon, Leonard I (2018) Making HSCs in vitro: don't forget the hemogenic endothelium. Blood 132:1372-1378
Cesana, Marcella; Guo, Michael H; Cacchiarelli, Davide et al. (2018) A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development. Cell Stem Cell 22:575-588.e7
Canver, Matthew C; Lessard, Samuel; Pinello, Luca et al. (2017) Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci. Nat Genet 49:625-634
Blaser, Bradley W; Moore, Jessica L; Hagedorn, Elliott J et al. (2017) CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment. J Exp Med 214:1011-1027
Perlin, Julie R; Robertson, Anne L; Zon, Leonard I (2017) Efforts to enhance blood stem cell engraftment: Recent insights from zebrafish hematopoiesis. J Exp Med 214:2817-2827
Doulatov, Sergei; Vo, Linda T; Macari, Elizabeth R et al. (2017) Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci Transl Med 9:
Lessard, Samuel; Francioli, Laurent; Alfoldi, Jessica et al. (2017) Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci. Proc Natl Acad Sci U S A 114:E11257-E11266

Showing the most recent 10 out of 98 publications